The Lancet Regional Health. Western Pacific (Aug 2023)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore

  • Rachael Pung,
  • Xin Peng Kong,
  • Lin Cui,
  • Sae-Rom Chae,
  • Mark I-Cheng Chen,
  • Vernon J. Lee,
  • Zheng Jie Marc Ho

Journal volume & issue
Vol. 37
p. 100849

Abstract

Read online

Summary: Several XBB subvariants such as XBB.1.5, XBB.1.9, XBB.1.16 and XBB.2.3 co-circulate in Singapore. Despite the different viral properties of XBB.1.16 as compared to other XBB subvariants, comparison on their severity is limited. In this study, we investigate the outcomes of hospitalisation and severe COVID-19 infection in individuals infected with different XBB subvariants, adjusted for potential confounders such as age and vaccination history. Overall, our preliminary analysis showed that the risk of severe outcomes when infected with XBB.1.16 is higher than that of XBB.1.5 or XBB.1.9 but there is no difference in the risk of hospitalisation across different XBB subvariants.